 DUBLIN , Oct. 25, 2022 PRNewswire -- Theravance Biopharma, Inc. Theravance Biopharma or the Company NASDAQ: TBPH today announced new ampreloxetine data in neurogenic orthostatic hypotension nOH will be presented at the 33rd International Symposium on the Autonomic Nervous System, a meeting of the American Autonomic Society, taking place November 2-5, 2022, in Maui, Hawaii. The data include three consecutive platform presentations on Wednesday, November 2, 2022, starting at 11:15 AM Maui, HI 5:15 PM ET 2:15 PM PT 9:15 PM GMT: Biaggioni I, et al. 